Skip to main content

MoneyWorks4Me

Astec Lifesciences informs about statement of investor complaints

18 Oct 2017 Evaluate

Astec Lifesciences has informed about Statement of Investor Complaints as per Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended 30th September, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
UPL 536.00
PI Industries 1735.00
Bayer CropScience 3316.50
Sharda Cropchem 685.80
Sumitomo Chem. India 328.60
View more..